Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Very positive. Challenging but fair. Opportunity to grow.
Was macht Sie bei der Arbeit am glücklichsten?
The opportunity to save and extend life.
Was gefällt dir am besten am Führungsteam?
Communication. Confidence. Strategic. Flexible. Resilient.
Was sind einige der besten Dinge an Ihrem Team?
The team works well together and are likable.
Was ist das Beste an Ihrem Vergütungspaket?
Equity. Salary. Ignite Points. Car.
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Belief we are helping patients.
Other Employee Reviews for Karyopharm Therapeutics
×